Search Results - Hongchao Li

Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study by Yue Ma, Yue Ma, Yuxin Li, Yuxin Li, Aixia Ma, Aixia Ma, Hongchao Li, Hongchao Li

Connect to this object online.

A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia by Luying Wang, Luying Wang, Fenghao Shi, Fenghao Shi, Xin Guan, Xin Guan, He Xu, He Xu, Jing Liu, Hongchao Li, Hongchao Li

Connect to this object online.

Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC by Pingyu Chen, Pingyu Chen, Xintian Wang, Shengwen Zhu, Hongchao Li, Hongchao Li, Mingjun Rui, Yingcheng Wang, Haikui Sun, Aixia Ma, Aixia Ma

Connect to this object online.

Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients by Lei Tian, Shihui Fu, Mengyuan Li, Xinrui Zhao, Hongchao Li

Connect to this object online.

Economic Burden of Myocardial Infarction Combined With Dyslipidemia by Pingyu Chen, Pingyu Chen, Mengran Zhang, Yan Zhang, Xi Su, Jiyan Chen, Biao Xu, Jianhong Tao, Zhen Wang, Aixia Ma, Aixia Ma, Hongchao Li, Hongchao Li

Connect to this object online.

Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US by Yingcheng Wang, Yingcheng Wang, Mingjun Rui, Mingjun Rui, Lan Yang, Lan Yang, Xintian Wang, Xintian Wang, Ye Shang, Ye Shang, Aixia Ma, Aixia Ma, Hongchao Li, Hongchao Li

Connect to this object online.

Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis by Qiran Wei, Qiran Wei, Jiting Zhou, Jiting Zhou, Hongchao Li, Hongchao Li, Luying Wang, Luying Wang, Yao Wu, Yao Wu, Aixia Ma, Aixia Ma, Xin Guan, Xin Guan

Connect to this object online.

The Relationship Between Short-Term Surrogate Endpoint Indicators and mPFS and mOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non... by Mingjun Rui, Mingjun Rui, Zijing Wang, Zijing Wang, Zhengyang Fei, Zhengyang Fei, Yao Wu, Yao Wu, Yingcheng Wang, Yingcheng Wang, Lei Sun, Ye Shang, Ye Shang, Hongchao Li, Hongchao Li

Connect to this object online.

Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma by Ting Zhou, Xintian Wang, Yingdan Cao, Lan Yang, Zijing Wang, Aixia Ma, Hongchao Li

Connect to this object online.

Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma by Pingyu Chen, Chang Fu, Lin Shen, Zhengyang Fei, Mengjie Luo, Yanqiu Chen, Hongchao Li

Connect to this object online.

Corrigendum: AMPK activation alleviates myocardial ischemia-reperfusion injury by regulating Drp1-mediated mitochondrial dynamics by Jingxia Du, Hongchao Li, Jingjing Song, Tingting Wang, Yibo Dong, An Zhan, Yan Li, Gaofeng Liang

Connect to this object online.

AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics by Jingxia Du, Hongchao Li, Jingjing Song, Tingting Wang, Yibo Dong, An Zhan, Yan Li, Gaofeng Liang

Connect to this object online.

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis by Donger Zhang, Donger Zhang, Xia Li, Xia Li, Jing Ding, Xiatong Ke, Xiatong Ke, Wenpei Ding, Wenpei Ding, Yinan Ren, Yinan Ren, He Xu, He Xu, Hongchao Li, Hongchao Li, Aixia Ma, Aixia Ma, Wenxi Tang, Wenxi Tang

Connect to this object online.

Predictors of Quality of Life in Patients With Myocardial Infarction Combined With Dyslipidemia by Mengran Zhang, Pingyu Chen, Yan Zhang, Xi Su, Jiyan Chen, Biao Xu, Jianhong Tao, Zhen Wang, Hongchao Li, Aixia Ma

Connect to this object online.